Bachem is the leading independent supplier of peptidic active pharmaceutical ingredients (APIs) for the human and veterinary pharmaceutical market. Since its foundation in 1971, Bachem's concepts and technologies pioneered the industrial peptide manufacturing. Our pioneering mindset drives us to continue developing innovations and offering all integrated services needed to bring our partner's breakthroughs to market.
Bachem offers the world's largest collection of amino acid derivatives, linkers and reagents for peptide synthesis. In addition, solid phase supports for different synthesis strategies are available. Other key research products are bioactive peptides, enzyme substrates and inhibitors as well as organic molecules. New products are continuously added to meet new demands for innovative and high quality research chemicals.
Our custom-made peptide service supports lead finding and optimisation during preclinical development. Close collaboration with Bachem experts allows further refining of target compounds and consequent project advancement. A strong partnership is key to come up with pioneering concepts and molecules to bring into clinical development.
Our partners can trust in our support and guidance from early development and selection of the lead compound, throughout all clinical phases and final drug approval. Each production step is scrutinised in order to guarantee manufacturing reproducibility and scale-up possibilities. Process validation and control is the result of the intense partnership between Bachem and our customers.
As a leading peptide Contract Manufacturing Organization, we guarantee the reliable supply of the drug substance by coordinating our activities closely with our partners. Bachem is currently involved in more than 150 cGMP development projects targeting new chemical entities (NCEs) and offers a range of more than 30 generic drug substances. We have the capacity to produce peptide APIs from gram scale up to annual quantities of hundreds of kilograms and small molecules APIs from gram scale up to annual quantities of tens of tons. The FDA and local authorities regularly inspect our GMP manufacturing facilities, located in Switzerland and the United States.
In addition to close to 50 years of experience in the manufacture of drug substance, Bachem also has a strong regulatory background. We are well prepared to fully support our customers with the required regulatory documentation such as drug master files (DMFs). For complex development projects, we support our customers with dedicated project teams comprising of our experts from R&D, production, quality control, quality assurance and regulatory affairs. A team of experienced business development managers and generics managers look forward to working with our customers for their future requirements. Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the Bachem group has a global reach. Bachem shows total commitment to quality, innovation and partnership.